惠程科技(002168.SZ):擬向深圳高新投申請3000萬元信用貸款
格隆匯 11 月 5日丨惠程科技(002168.SZ)公告,為滿足公司資金需要,董事會同意公司向深圳市高新投集團有限公司(以下簡稱“高新投”)申請通過北京銀行股份有限公司深圳分行以委託貸款的形式發放的信用貸款,貸款額度為人民幣3000萬元,貸款期限為六個月,貸款利息的年利率為6.3%,實際金額、期限、利率、幣種等以高新投的最終審批結果為準,公司董事長汪超湧為上述貸款提供連帶責任保證擔保,並授權公司董事長汪超湧簽署上述貸款事項的相關法律文件。
汪超湧為公司的董事長,根據《深圳證券交易所股票上市規則》等規定,本次交易構成公司的關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.